CLINICAL_TRIALS
trial_result
· 2024-11-19
Clinical Trial Update: P20 Extending Sleep to Reverse Metabolic Syndrome [NA]
Summary
The P20 trial evaluating extending sleep to reverse metabolic syndrome has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: NYU Langone Health | Conditions: Metabolic Syndrome | NA | Status: COMPLETED | Results posted: 2024-11-19